A recent scientific breakthrough by Russian researchers has revealed a promising mechanism that could accelerate the development of new treatments for Parkinson’s disease.
The study found that a modified form of the protein CRYAB, which accumulates in the cells of patients with diabetes, plays an active role in breaking down toxic protein aggregates associated with Parkinson’s disease. According to the press service of the Russian Science Foundation, this discovery could significantly support efforts to develop new therapeutic drugs.
The research, led by Vladimir Moronets of the Institute of Physico-Chemical Biology at Lomonosov Moscow State University, offers fresh insight into the relationship between diabetes and Parkinson’s disease. It also sheds light on how the brain’s natural defence mechanisms can be stimulated in the early stages of neurodegenerative disorders.
Researchers explained that CRYAB plays a crucial protective role by preventing the structural breakdown of proteins under stress conditions, such as elevated body temperature—situations commonly observed during infectious diseases. The protein is found in high concentrations in the eye lens and in various cell types, including neurons in the brain, where it contributes to protecting against the progression of Parkinson’s disease.
The study focused on how the structure of CRYAB changes and how it interacts with toxic peptide aggregates in patients suffering from both Parkinson’s disease and diabetes. Scientists hypothesised that elevated glucose levels may lead to chemical modifications of the protein, significantly altering its structure and enhancing its activity.
The findings suggest that the properties of CRYAB could potentially be adjusted through targeted mutations to achieve desired therapeutic effects. Researchers hope that a deeper understanding of this mechanism will not only aid in developing new treatments for Parkinson’s disease but also broaden scientific knowledge of how diabetes influences the progression of other chronic conditions.
